About
About Sisram Medical Ltd
Sisram Medical Ltd, together with its subsidiaries, engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America. The company offers a portfolio of products and treatments for clinical aesthetic indications, including hair removal, skin rejuvenation, acne and acne scars, trans-epidermal delivery, face and body contouring, cellulite treatment, stretch marks, vascular and pigmented lesions, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodeling, injectables, personal care, aesthetic dentistry, hydradermabrasion, blepharoplasty (nonsurgical eyelid lift), liposuction, feminine health, and sexual rehabilitation. It also engages in pharmaceutical research and development activities. The company offers its products under the Alma, LMNT, Copulla, Profhilo, and Aliaxin brands. Sisram Medical Ltd was founded in 1999 and is headquartered in Caesarea, Israel.
Visit company website
5 years, 4 months ago
Sisram Medical Ltd is currently in a long term uptrend where the price is trading 163.9% above its 200 day moving average.
From a valuation standpoint, the stock is 98.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Sisram Medical Ltd's total revenue rose by 2.6% to $90M since the same quarter in the previous year.
Its net income has increased by 3.5% to $8M since the same quarter in the previous year.
Finally, its free cash flow grew by 271.0% to $11M since the same quarter in the previous year.
Based on the above factors, Sisram Medical Ltd gets an overall score of 5/5.